-
1دورية أكاديمية
المؤلفون: Jana B. Adizie, MbChB., MRCP, MD, Judith Tweedie, MD, Aamir Khakwani, PhD, Emily Peach, PhD, Richard Hubbard, PhD, Natasha Wood, BSc, John R. Gosney, MD, Susan V. Harden, DM(Oxon), Paul Beckett, MD, Sanjay Popat, PhD, Neal Navani, MA, MSc, PhD, FRCP
المصدر: JTO Clinical and Research Reports, Vol 2, Iss 6, Pp 100176- (2021)
مصطلحات موضوعية: Non–small cell lung cancer, Mutation testing, Biomarkers, Targeted therapy, Personalized medicine, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: http://www.sciencedirect.com/science/article/pii/S2666364321000357Test; https://doaj.org/toc/2666-3643Test
-
2
المؤلفون: Aamir Khakwani, Paul Beckett, John R. Gosney, Richard Hubbard, Susan Harden, J.B. Adizie, Natasha Wood, Neal Navani, Emily Peach, Sanjay Popat, Judith Tweedie
المصدر: JTO Clinical and Research Reports
JTO Clinical and Research Reports, Vol 2, Iss 6, Pp 100176-(2021)مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, medicine.drug_class, medicine.medical_treatment, Mutation testing, Tyrosine-kinase inhibitor, Targeted therapy, Internal medicine, medicine, Non–small cell lung cancer, Lung cancer, RC254-282, Performance status, business.industry, Public health, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Personalized medicine, Biomarker (medicine), Adenocarcinoma, Original Article, business, Biomarkers
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df9c90b442c67b0f4790b8cff82f2a28Test
https://doi.org/10.1016/j.jtocrr.2021.100176Test